Skip to Content

Daring to Make a Difference

Join Revance

Revance announces addition of fintech platform for aesthetic practices with acquisition of HintMD

Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings

Aesthetics

We are building a powerful premium aesthetics category focused on differentiated products, improved outcomes, and an elevated experience for healthcare professionals and patients.

Learn More

Therapeutics

We are evaluating therapeutic indications in muscle movement and pain disorders to meaningfully transform patient experiences.

Learn More

Facts, Figures & Trends

Neuromodulators are the most performed minimally invasive cosmetic procedures, followed by dermal fillers 1

Explore Aesthetics

There are 12 Approved Therapeutic Indications for Botulinum Toxin Type A in the U.S. and hundreds of potential indications 2

Explore Therapeutics
Investor Info

Stock Quote

$25.13 EXCHANGE NYSE (US DOLLAR)
0 VOLUME 304,064

Price could be delayed by up to 15 mins

References

  1. The American Society of Plastic Surgeons. 2018 Plastic Surgery Statistic Report. Available at: https://www.plasticsurgery.org/documents/News/Statistics/2018/plastic-surgery-statistics-full-report-2018.pdf.   Accessed July 2019
  2. Time Magazine, January 16, 2017, How BOTOX Became the Drug That’s Treating Everything. Available at: https://time.com/4623409/botox-drug-treating-everything/. Accessed April 2020
Back to top